Blood Mass Spectrometry Detects Residual Disease Better Than Standard Techniques in Light-Chain Amyloidosis

Blood Cancer Journal - United States
doi 10.1038/s41408-020-0291-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component in Systemic Light Chain Amyloidosis

Blood Cancer Journal
OncologyHematology
2019English

Localized Lymph Node Light Chain Amyloidosis

Case Reports in Hematology
2015English

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders

Case Reports in Medicine
Medicine
2016English

Multiorgan Involvement by Amyloid Light Chain Amyloidosis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Light Chain Amyloidosis: Patient Experience Survey From the Amyloidosis Research Consortium

Advances in Therapy
MedicinePharmacology
2015English

EGCG Inhibits Fibrillation of Light Chain 6aJL2-R24g, Associated With Light Chain Amyloidosis

Biophysical Journal
Biophysics
2018English

Longer-Term Survivors of Light Chain Cardiac Amyloidosis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Improvements in Cardiac Biomarkers Are Associated With Better Health-Related Quality of Life in Patients With Light Chain Amyloidosis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Cardiac Magnetic Resonance Strain Imaging in Systemic Light Chain Amyloidosis

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy